Cargando…
Screening for oesophageal neoplasia in patients with head and neck cancer
Due to advanced disease at the time of diagnosis the prognosis of oesophageal cancer is generally poor. As mass screening for oesophageal cancer is neither feasible nor reasonable, high-risk groups should be identified and surveilled. The aim of this study was to define the risk of oesophageal cance...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375180/ https://www.ncbi.nlm.nih.gov/pubmed/11870513 http://dx.doi.org/10.1038/sj.bjc.6600018 |
_version_ | 1782154595823255552 |
---|---|
author | Scherübl, H Lampe, B von Faiss, S Däubler, P Bohlmann, P Plath, T Foss, H-D Scherer, H Strunz, A Hoffmeister, B Stein, H Zeitz, M Riecken, E-O |
author_facet | Scherübl, H Lampe, B von Faiss, S Däubler, P Bohlmann, P Plath, T Foss, H-D Scherer, H Strunz, A Hoffmeister, B Stein, H Zeitz, M Riecken, E-O |
author_sort | Scherübl, H |
collection | PubMed |
description | Due to advanced disease at the time of diagnosis the prognosis of oesophageal cancer is generally poor. As mass screening for oesophageal cancer is neither feasible nor reasonable, high-risk groups should be identified and surveilled. The aim of this study was to define the risk of oesophageal cancer in patients with (previous) head and neck cancer. A total of 148 patients with (previous) head and neck cancer were prospectively screened for oesophageal cancer by video-oesophagoscopy and random oesophageal biopsies. Even in a macroscopically normal looking oesophagus, four biopsy specimens were taken every 3 cm throughout the entire length of the squamous oesophagus. Low- or high-grade squamous cell dysplasia was detected histologically in 10 of the 148 patients (6.8%). All but one dysplasias were diagnosed synchronously with the head and neck cancers. In addition, oesophageal squamous cell carcinoma was diagnosed in 11 of the 148 patients (7.4%). Most invasive cancers (63.6%) occurred metachronously. The risk of squamous cell neoplasia of the oesophagus is high in patients with (previous) head and neck cancer. Surveillance is recommended in this high-risk group. British Journal of Cancer (2002) 86, 239–243. DOI: 10.1038/sj/bjc/6600018 www.bjcancer.com © 2002 The Cancer Research Campaign |
format | Text |
id | pubmed-2375180 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2002 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23751802009-09-10 Screening for oesophageal neoplasia in patients with head and neck cancer Scherübl, H Lampe, B von Faiss, S Däubler, P Bohlmann, P Plath, T Foss, H-D Scherer, H Strunz, A Hoffmeister, B Stein, H Zeitz, M Riecken, E-O Br J Cancer Molecular and Cellular Pathology Due to advanced disease at the time of diagnosis the prognosis of oesophageal cancer is generally poor. As mass screening for oesophageal cancer is neither feasible nor reasonable, high-risk groups should be identified and surveilled. The aim of this study was to define the risk of oesophageal cancer in patients with (previous) head and neck cancer. A total of 148 patients with (previous) head and neck cancer were prospectively screened for oesophageal cancer by video-oesophagoscopy and random oesophageal biopsies. Even in a macroscopically normal looking oesophagus, four biopsy specimens were taken every 3 cm throughout the entire length of the squamous oesophagus. Low- or high-grade squamous cell dysplasia was detected histologically in 10 of the 148 patients (6.8%). All but one dysplasias were diagnosed synchronously with the head and neck cancers. In addition, oesophageal squamous cell carcinoma was diagnosed in 11 of the 148 patients (7.4%). Most invasive cancers (63.6%) occurred metachronously. The risk of squamous cell neoplasia of the oesophagus is high in patients with (previous) head and neck cancer. Surveillance is recommended in this high-risk group. British Journal of Cancer (2002) 86, 239–243. DOI: 10.1038/sj/bjc/6600018 www.bjcancer.com © 2002 The Cancer Research Campaign Nature Publishing Group 2002-01-21 /pmc/articles/PMC2375180/ /pubmed/11870513 http://dx.doi.org/10.1038/sj.bjc.6600018 Text en Copyright © 2002 The Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Molecular and Cellular Pathology Scherübl, H Lampe, B von Faiss, S Däubler, P Bohlmann, P Plath, T Foss, H-D Scherer, H Strunz, A Hoffmeister, B Stein, H Zeitz, M Riecken, E-O Screening for oesophageal neoplasia in patients with head and neck cancer |
title | Screening for oesophageal neoplasia in patients with head and neck cancer |
title_full | Screening for oesophageal neoplasia in patients with head and neck cancer |
title_fullStr | Screening for oesophageal neoplasia in patients with head and neck cancer |
title_full_unstemmed | Screening for oesophageal neoplasia in patients with head and neck cancer |
title_short | Screening for oesophageal neoplasia in patients with head and neck cancer |
title_sort | screening for oesophageal neoplasia in patients with head and neck cancer |
topic | Molecular and Cellular Pathology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375180/ https://www.ncbi.nlm.nih.gov/pubmed/11870513 http://dx.doi.org/10.1038/sj.bjc.6600018 |
work_keys_str_mv | AT scherublh screeningforoesophagealneoplasiainpatientswithheadandneckcancer AT lampebvon screeningforoesophagealneoplasiainpatientswithheadandneckcancer AT faisss screeningforoesophagealneoplasiainpatientswithheadandneckcancer AT daublerp screeningforoesophagealneoplasiainpatientswithheadandneckcancer AT bohlmannp screeningforoesophagealneoplasiainpatientswithheadandneckcancer AT platht screeningforoesophagealneoplasiainpatientswithheadandneckcancer AT fosshd screeningforoesophagealneoplasiainpatientswithheadandneckcancer AT schererh screeningforoesophagealneoplasiainpatientswithheadandneckcancer AT strunza screeningforoesophagealneoplasiainpatientswithheadandneckcancer AT hoffmeisterb screeningforoesophagealneoplasiainpatientswithheadandneckcancer AT steinh screeningforoesophagealneoplasiainpatientswithheadandneckcancer AT zeitzm screeningforoesophagealneoplasiainpatientswithheadandneckcancer AT rieckeneo screeningforoesophagealneoplasiainpatientswithheadandneckcancer |